Why the study?
Does intravenous neo-synephrine revert paroxysmal supraventricular tachycardia to normal sinus rhythm in nonhypertensive patients?
Does intravenous neo-synephrine revert paroxysmal supraventricular tachycardia to normal sinus rhythm in nonhypertensive patients?
Intravenous neo-synephrine successfully reverted paroxysmal supraventricular tachycardia to normal sinus rhythm in a small case series of nonhypertensive patients.
May support neosynephrine for rapid PSVT reversion; leaves open need for randomized confirmation of efficacy and safety.
Four nonhypertensive patients with idiopathic paroxysmal tachycardia of supraventricular origin were given neo-synephrine intravenously in amounts sufficient to increase the systolic blood pressure 30 to 40 mm of Hg. In 2 of these the attacks had persisted for several hours in spite of all mechanical methods of treatment and administration of mecholyl. In all 4 cases the rhythm reverted to normal within one minute after the injection of neosynephrine. This is considered to be produced by reflexes from the carotid sinuses and aortic arch. Occasional ventricular beats occurred during the 2-minute period after the return to the normal sinus rhythm. Blood pressure returned to normal within 4 to 8 minutes after the injection.
No takes yet. Share an insight, caveat, or question.
Youmans et al. (1947) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: